Serveur d'exploration Covid (26 mars) - Exploration (Accueil)

Index « AbsEn.i » - entrée « vaccines »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
vaccine < vaccines < vaccinia  Facettes :

List of bibliographic references indexed by vaccines

Number of relevant bibliographic references: 77.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000139 (2020) H Y Tian [République populaire de Chine][2019-nCoV: new challenges from coronavirus].
000182 (2020) Daniel B. JerniganUpdate: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020.
000210 (2020) Shan Lu [États-Unis]Timely development of vaccines against SARS-CoV-2.
000237 (2020) Weilong Shang ; Yi Yang ; Yifan Rao ; Xiancai RaoThe outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
000264 (2020) Jin-Yan Li [République populaire de Chine] ; Zhi You [République populaire de Chine] ; Qiong Wang [République populaire de Chine] ; Zhi-Jian Zhou [République populaire de Chine] ; Ye Qiu [République populaire de Chine] ; Rui Luo [République populaire de Chine] ; Xing-Yi Ge [République populaire de Chine]The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future.
000467 (2020) Syed Faraz Ahmed [République populaire de Chine] ; Ahmed A. Quadeer [République populaire de Chine] ; Matthew R. Mckay [République populaire de Chine]Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.
000480 (2020) Lei Zhang [République populaire de Chine] ; Yunhui Liu [République populaire de Chine]Potential interventions for novel coronavirus in China: A systematic review.
000486 (2020) David A. Schwartz [États-Unis] ; Ashley L. GrahamPotential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections
000488 (2020) Xiaolong Tian [République populaire de Chine] ; Cheng Li [République populaire de Chine] ; Ailing Huang [République populaire de Chine] ; Shuai Xia [République populaire de Chine] ; Sicong Lu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Lu Lu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine] ; Zhenlin Yang [République populaire de Chine] ; Yanling Wu [République populaire de Chine] ; Tianlei Ying [République populaire de Chine]Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.
000490 (2020) Francesco Di Pierro [Oman] ; Alexander Bertuccioli [Italie] ; Ilaria Cavecchia [Italie]Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.
000506 (2020) Balamurugan Shanmugaraj [Thaïlande] ; Konlavat Siriwattananon [Thaïlande] ; Kittikhun Wangkanont [Thaïlande] ; Waranyoo Phoolcharoen [Thaïlande]Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
000669 (2020) Vargab Baruah [Inde] ; Sujoy Bose [Inde]Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV.
000670 (2020) Eakachai Prompetchara [Thaïlande] ; Chutitorn Ketloy [Thaïlande] ; Tanapat Palaga [Thaïlande]Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.
000726 (2020) Sara Cleemput [Belgique] ; Wim Dumon [Belgique] ; Vagner Fonseca [Afrique du Sud] ; Wasim Abdool Karim [Afrique du Sud] ; Marta Giovanetti [Brésil] ; Luiz Carlos Alcantara [Brésil] ; Koen Deforche [Belgique] ; Tulio De Oliveira [Afrique du Sud]Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes.
000748 (2020) Atte Sandelin [Finlande] ; Heidi H Rtel ; Leena Sepp Lassila [Finlande] ; Liisa Kaartinen [Finlande] ; Helena Rautala [Finlande] ; Timo Soveri [Finlande] ; Heli Simojoki [Finlande]Field trial to evaluate the effect of an intranasal respiratory vaccine protocol on bovine respiratory disease incidence and growth in a commercial calf rearing unit
000781 (2020) Jianhui Nie [République populaire de Chine] ; Qianqian Li [République populaire de Chine] ; Jiajing Wu [République populaire de Chine] ; Chenyan Zhao [République populaire de Chine] ; Huan Hao [République populaire de Chine] ; Huan Liu [République populaire de Chine] ; Li Zhang [République populaire de Chine] ; Lingling Nie [République populaire de Chine] ; Haiyang Qin [République populaire de Chine] ; Meng Wang [République populaire de Chine] ; Qiong Lu [République populaire de Chine] ; Xiaoyu Li [République populaire de Chine] ; Qiyu Sun [République populaire de Chine] ; Junkai Liu [République populaire de Chine] ; Changfa Fan [République populaire de Chine] ; Weijin Huang [République populaire de Chine] ; Miao Xu [République populaire de Chine] ; Youchun Wang [République populaire de Chine]Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2.
000826 (2020) Manisha Prajapat ; Phulen Sarma ; Nishant Shekhar ; Pramod Avti ; Shweta Sinha ; Hardeep Kaur ; Subodh Kumar ; Anusuya Bhattacharyya ; Harish Kumar ; Seema Bansal ; Bikash MedhiDrug targets for corona virus: A systematic review
000828 (2020) Shibo JiangDon't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees.
000A45 (2020) Wanbo Tai [États-Unis] ; Lei He [République populaire de Chine] ; Xiujuan Zhang [États-Unis] ; Jing Pu [États-Unis, République populaire de Chine] ; Denis Voronin [États-Unis] ; Shibo Jiang [États-Unis, République populaire de Chine] ; Yusen Zhou [République populaire de Chine] ; Lanying Du [États-Unis]Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
000A46 (2020) Sheng-Qun Deng ; Hong-Juan PengCharacteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China
000B27 (2020) Kuldeep Dhama [Inde] ; Khan Sharun [Inde] ; Ruchi Tiwari [Inde] ; Maryam Dadar [Iran] ; Yashpal Singh Malik [Inde] ; Karam Pal Singh [Inde] ; Wanpen Chaicumpa [Thaïlande]COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "vaccines" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "vaccines" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    vaccines
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021